169 related articles for article (PubMed ID: 24680117)
1. [Severe hypercalcemia revealing sarcoidosis precipitated by etanercept].
Watrin A; Royer M; Legrand E; Gagnadoux F
Rev Mal Respir; 2014 Mar; 31(3):255-8. PubMed ID: 24680117
[TBL] [Abstract][Full Text] [Related]
2. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients.
Verschueren K; Van Essche E; Verschueren P; Taelman V; Westhovens R
Clin Rheumatol; 2007 Nov; 26(11):1969-71. PubMed ID: 17340045
[TBL] [Abstract][Full Text] [Related]
3. Development of pulmonary and cardiac sarcoidosis during etanercept therapy.
Miyagi R; Ideguchi H; Soga T; Yamakawa Y; Otsuki H; Niino H; Shiina T; Ueda A; Ishigatsubo Y
Int J Rheum Dis; 2014 Sep; 17(7):810-2. PubMed ID: 24460777
[No Abstract] [Full Text] [Related]
4. Systemic sarcoidosis induced by etanercept: first Brazilian case report.
Unterstell N; Bressan AL; Serpa LA; Fonseca e Castro PP; Gripp AC
An Bras Dermatol; 2013; 88(6 Suppl 1):197-9. PubMed ID: 24346918
[TBL] [Abstract][Full Text] [Related]
5. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
Gifre L; Ruiz-Esquide V; Xaubet A; Gómez-Puerta JA; Hernández MV; Sanmartí R
Arch Bronconeumol; 2011 Apr; 47(4):208-12. PubMed ID: 20638761
[TBL] [Abstract][Full Text] [Related]
6. [Life-threatening hypercalcemia and acute kidney injury induced by etanercept].
Tsevi YM; Aydin S; Durez P; Labriola L
Nephrol Ther; 2018 Nov; 14(6):478-482. PubMed ID: 30401463
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
Clementine RR; Lyman J; Zakem J; Mallepalli J; Lindsey S; Quinet R
J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
[TBL] [Abstract][Full Text] [Related]
8. Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?
Haroon M; Ryan JG; Harney S
Clin Rheumatol; 2011 Aug; 30(8):1095-8. PubMed ID: 21380931
[TBL] [Abstract][Full Text] [Related]
9. Granulomatous disease in a child treated with etanercept.
Alhajri M; Aljumaah S; Aleyouni Y; Al-Qahtani F; Alhazzaa S; Al-Mayouf SM
Int J Rheum Dis; 2013 Aug; 16(4):472-4. PubMed ID: 23826822
[No Abstract] [Full Text] [Related]
10. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication.
Tong D; Manolios N; Howe G; Spencer D
Intern Med J; 2012 Jan; 42(1):89-94. PubMed ID: 22389903
[TBL] [Abstract][Full Text] [Related]
11. Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy.
Vigne C; Tebib JG; Pacheco Y; Coury F
Joint Bone Spine; 2013 Jan; 80(1):104-7. PubMed ID: 22885144
[No Abstract] [Full Text] [Related]
12. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases.
Daïen CI; Monnier A; Claudepierre P; Constantin A; Eschard JP; Houvenagel E; Samimi M; Pavy S; Pertuiset E; Toussirot E; Combe B; Morel J;
Rheumatology (Oxford); 2009 Aug; 48(8):883-6. PubMed ID: 19423648
[TBL] [Abstract][Full Text] [Related]
13. Abrupt development of sarcoidosis with a prodromal increase in plasma osteopontin in a patient with rheumatoid arthritis during treatment with etanercept.
Takatori S; Kamata Y; Murosaki T; Iwamoto M; Minota S
J Rheumatol; 2010 Jan; 37(1):210-1. PubMed ID: 20040649
[No Abstract] [Full Text] [Related]
14. Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis.
Durel CA; Feurer E; Pialat JB; Berthoux E; Chapurlat RD; Confavreux CB
BMC Neurol; 2013 Dec; 13():212. PubMed ID: 24373564
[TBL] [Abstract][Full Text] [Related]
15. Development of sarcoidosis following etanercept treatment: a report of three cases.
Skoie IM; Wildhagen K; Omdal R
Rheumatol Int; 2012 Apr; 32(4):1049-53. PubMed ID: 20062997
[TBL] [Abstract][Full Text] [Related]
16. Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab.
Dragnev D; Barr D; Kulshrestha M; Shanmugalingam S
BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24005973
[TBL] [Abstract][Full Text] [Related]
17. Uveitis associated with sarcoidosis exacerbated by etanercept therapy.
Suzuki J; Goto H
Jpn J Ophthalmol; 2009 Jul; 53(4):439-40. PubMed ID: 19763766
[No Abstract] [Full Text] [Related]
18. [Sarcoïdosis and anti-TNF: a paradoxical class effect? Analysis of the French Pharmacovigilance system database and literature review].
Javot L; Tala S; Scala-Bertola J; Massy N; Trenque T; Baldin B; Andréjak M; Gillet P; Petitpain N;
Therapie; 2011; 66(2):149-54. PubMed ID: 21635863
[TBL] [Abstract][Full Text] [Related]
19. Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept.
Vieira MA; Saraiva MI; Silva LK; Fraga RC; Kakizaki P; Valente NY
Rev Assoc Med Bras (1992); 2016 Nov; 62(8):718-720. PubMed ID: 27992009
[TBL] [Abstract][Full Text] [Related]
20. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
